1Folkman J. Angiogenesis and tumor growth. N Engl J Med, 1995,333: 1757-1763.
2Lee TY, Belesky V, Kalapos P, et al. CT perfusion imaging in cerebral is- ehemia. Stroke, 2005,36 : 1-3.
3Lezzoni JC, Mills SE, Pelkey TJ, et al. Inhibin is not an immunohisto- chemical marker for hepatocellular carcinoma. An example of the poten-tial pitfall in diagnostic immunohistoehemist caused by endogenous. Am J Clin Pathol, 1999,111:229-234.
4Wang H,Pevsner J. Detection of endogenous biotin in various tissues:no- vel functions in the hippocampus and implications for itsuse in avidinbi-otin technologh. Cell Tissue Res, 1999,296:511-516.
5Cooper K, Haffajee Z, Taylor L. Comparative analysis of biotin in-trannclear inclusions ofgestational endometrium using theAPAAP, AB- Cand the PAP immunodetection systems. J Clin Pathol, 1997,50: 153- 156.
6Sabattini E,Bisgaard K,Ascani S,et al. The EnVision system:a new im- munnohistochemical method for diagnostics and research critical compari-son with the APAAP,ChemMate,CSA,LABC and SABC techniques. JC- lin Pathol, 1998,51:506-511.
9Obermair A, Wanner C, Bilgi S, et al. Tumor angiogenesis in stage IB cer- vical cancer:correlation of microvessel density with survival. Am J Obstet Gynecol, 1998,178:314-319.
10Rogatsch H, Hittmair A, Reissigl A, et al. Microvessel density in core bi- opsies of prostatic adenocarcinoma: A stage predictor. Med J Pathol, 1997,182:205-210.
4Ferrara N, Davis ST. The biology of vascular endothelial growth factor. Endocr Rev ,1997,18( 1 ) :4.
5Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol, 1998,184 (2) : 119.
6Fujiwaki R, Hata K, Iida K, et al. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis ,tumor cell proliferation,and apoptosis. Anticancer Res,2000,20 ( 2B ) : 1317.
7Dobbs SP, Hewett PW,Johnson IR, et al. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer, 1997,76 ( 11 ) : 1410.
8Neufeld G, Cohen T, C, engrinovitch S, et al. Vascular endothelial growth factor and its receptors. FASEB J,1999,13(1) :9.
9Olofsson B, Pajusola K, Kaipalnen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Nail Acad Sci USA, 1996,93 (6) :2576.
10Olofsson B, Korpelainen E, Pepper MS, et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Nail Acad Sci USA,1998,95 (20) :11709.
